Figure 1.

Rsv potentiates the cytotoxic effects of TMZ in human glioma cells. U87 glioma cells were treated with the indicated doses of Rsv (30 or 100 μM), TMZ or combinations for 48 h, followed by cell counting; control cells were considered 100%; *p<0.05 and **p<0.01, in relation to control; a p<0.05 and b p<0.01 in relation to TMZ and Rsv alone, respectively.

Filippi-Chiela et al. BMC Cancer 2013 13:147   doi:10.1186/1471-2407-13-147
Download authors' original image